WFL — Wellfully Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -134.96% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 2.74 | 1.48 | 1.2 | 2.64 | 1.51 | n/a | n/a | -5.87% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Wellfully Limited is an Australia-based fully integrated, science-based wellness company. The Company has developed physical enhancement technologies based on the interactions between ingredient molecules and weak atomic forces. Its brands include REDUIT and SWISSWELL. Its REDUIT brand designs technology-enhanced skincare and haircare treatments, and its technologies include ultrasonic diffusion and magnetic misting. SWISSWELL is a biotechnology brand that offers a technology-enhanced joint management system, the Swisswell Knee Patch. Swisswell is an adhesive knee patch worn on the knee to lubricate the joint before, during and after physical activity. It also offers a portfolio of technologies and support partners by providing Internet Protocol (IP) and has capabilities in magnetic array design, and claims testing, engineering and production. It is focused on both large and small companies across a range of market sectors, including cosmetics and skincare, and consumer healthcare.
Directors
- Antonio Varano NEC (60)
- Paul Peros CEO
- Sergej Dolezil CFO
- Jeffery Edwards MDR
- Kevin Hammond OTH
- Henko Vos SEC
- Steven Schapera NED
- Anthony Wright NED
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 22nd, 1992
- Public Since
- May 29th, 2000
- No. of Employees
- 36
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 492,944,138
- Address
- 284 Oxford Street, LEEDERVILLE, 6007
- Web
- https://www.obj.com.au/
- Phone
- +61 894433011
- Auditors
- RSM Australia Partners
Upcoming Events for WFL
Similar to WFL
Actinogen Medical
Australian Stock Exchange - SEATS
Adalta
Australian Stock Exchange - SEATS
Algorae Pharmaceuticals
Australian Stock Exchange - SEATS
Alterity Therapeutics
Australian Stock Exchange - SEATS
Amplia Therapeutics
Australian Stock Exchange - SEATS
FAQ
As of Today at 24:04 UTC, shares in Wellfully are trading at AU$0.00. This share price information is delayed by 15 minutes.
Shares in Wellfully last closed at AU$0.00 and the price had moved by -92.5% over the past 365 days. In terms of relative price strength the Wellfully share price has underperformed the ASX All Ordinaries Index by -92.77% over the past year.
There is no consensus recommendation for this security.
Find out moreWellfully does not currently pay a dividend.
Wellfully does not currently pay a dividend.
Wellfully does not currently pay a dividend.
To buy shares in Wellfully you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.00, shares in Wellfully had a market capitalisation of .
Here are the trading details for Wellfully:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: WFL
Based on an overall assessment of its quality, value and momentum Wellfully is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Wellfully. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -84.57%.
As of the last closing price of AU$0.00, shares in Wellfully were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Wellfully PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Wellfully's management team is headed by:
- Antonio Varano - NEC
- Paul Peros - CEO
- Sergej Dolezil - CFO
- Jeffery Edwards - MDR
- Kevin Hammond - OTH
- Henko Vos - SEC
- Steven Schapera - NED
- Anthony Wright - NED